**Appendix C: Technical Support Documents**  Additional documentation in support of this RED is maintained in the OPP docket, located in room S

- 4400, One Potomac Yard (South Building), 2777 S. Cry stal Drive, Arlington, VA 22202 . I t is open Monday through Frid ay , excluding legal holiday s, from 8:30 am to 4 pm. All documents, in hard copy form, may

be viewed in the OPP docket room or downloaded or viewed via the Internet at the following site: http://www.regulations.g ov These documents include: **HED Documents:** Py rethrins: Human Health Aggregate Risk Assessment to Account for Pet Spray Ues Rate Correction. T. Dole; D347781; January 24, 2008. Py rethrins: Occupational and Residential Exposure Assessment to Account for Pet Spray Use Rate Correction. T. Dole; D347780; January 4, 2008. Py rethrins: Revised Human Health Risk Assessment for the Reregistration Eligibility Decision. Olinger, C.; D326648; March 16, 2006. Py rethrins: Responses to Public Comments on HE D Risk Assessment and Supporting Documents; Olinger, C., et al.; D 324662 ; January 31, 2006. Review of Py

rethrins Incident Reports

- Second Revision. Blondell, J.; D320300; August 16, 2005. Three P yrethrin H ealth Effects Reviews: Mosby and Registrant Submissions. Allen, Ruth; D326085; July

2006. Py rethrins. Revised Residue Chemistry Considerations for Reregistration Eligibility Decision. Deluzio, J. and Olinger, C.; D 318633 ; September 8, 2005. Py rethrins RED

- Reregistration Eligibility Decision. Product Chemistry Considerations. Deluzio, Joseph; D 309022 ; March 21, 2005. Py rethrins: Repo rt of the Cancer Assessment Review Committee (Third Evaluation). Kidwell, Jessica; TXR No.0052631, June 22, 2004. Py rethrins. Ac ute and Chronic Dietary Exposure Assessment for the Reassessment Eligibility

Decision (RED) Document. Deluzio, Joseph; D295748; December 20, 2004.
PYRETHRI

NS Reregistration Branch 1/Health Effects Division Response to Comments on Draft Risk Assessment. Tay lor, Linda; D320383; TXR # 0053661, August 17, 2005.Py

rethrins: 2 nd Revised Occupational and Residential Exposure Assessment and R ecommendatio ns for the Reregistration Eligibility Decision (RED). Dole, T. and L loy d, M.; D318630 ; Sept ember 7, 2005

. Occupational and Residential Exposure Assessment for the Use of P yr ethrin in Residential Mosquito Mister Sy stems. Dole, Timothy ; D315335; September 7, 2005. Piperony l Butoxide (PBO), Py rethrins and MGK

- 264: Health Effects Division’s response to the Registrant’s concerns for using metaplasia seen in the lary nx in subchronic inhalation studies as an endpoint for inhalation risk assessment. Ramasam y, S., et al.; D319913, D319914, and D320298; September 8, 2005. Py rethrins: Occupational Exposure Assessment for Indoor Fogging Applications. Dole, T.; D330441; July

5, 2006. Revised Occupational and Residential Exposure Assessment for the Use of Py rethrins in Residential Mosquito Mister Sy stems. Dole, T.; D330442; July 5, 2006. **EFED Documents:** Revised Py

rethrins RED Chapter After Additional 60

- Day Comment Period, Phase 5. Rexrode, M. and Meléndez, J. ; D324663; January 25, 2006. Response to Comments of Phase 5 Period About Water Quality , and Other I ssues on the Revised Draft EFED RED Chapters for P yr ethrins, PBO and MGK

- 264. Dav y, M., et al.; D324663, D324664, D324667, D324662, D324671, and D32 4673; January 30 , 2006. Tier 1 Estimated Drinking Water Concentrations of Py rethrin and Derivatives for use in Human Health Risk Assessment. Dutta, Subijoy ; D295750; August 19, 2004.